| Circulating levels of prolactin are elevated in patients with rheumatoid arthritis: a meta-analysis |
45 |
| Chronic periodontitis, inflammatory cytokines, and interrelationship with other chronic diseases |
44 |
| SGLT2 inhibitors in patients with type 2 diabetes and renal disease: overview of current evidence |
18 |
| Incidence of nonmedical use of OxyContin and other prescription opioid pain relievers before and after the introduction of OxyContin with abuse deterrent properties |
17 |
| A proposed definition of remission from chronic pain, based on retrospective evaluation of 24-month outcomes with spinal cord stimulation |
16 |
| Efficacy and renal outcomes of SGLT2 inhibitors in patients with type 2 diabetes and chronic kidney disease |
16 |
| High-frequency spinal cord stimulation at 10 kHz for widespread pain: a retrospective survey of outcomes from combined cervical and thoracic electrode placements |
16 |
| How blockchain technology can change medicine |
15 |
| SGLT2 inhibitors and cardioprotection: a matter of debate and multiple hypotheses |
15 |
| Physical frailty and cognitive impairment is associated with diabetes and adversely impact functional status and mortality |
14 |
| The eicosapentaenoic acid:arachidonic acid ratio and its clinical utility in cardiovascular disease |
14 |
| Safety and tolerability of new-generation anti-obesity medications: a narrative review |
13 |
| Management of hypoglycemia in older adults with type 2 diabetes |
12 |
| Reframing chronic pain as a disease, not a symptom: rationale and implications for pain management |
11 |
| The single use of body mass index for the obesity paradox is misleading and should be used in conjunction with other obesity indices |
11 |
| Depression, anxiety and acute pain: links and management challenges |
11 |
| Increased prevalence of depression and anxiety among subjects with metabolic syndrome and known type 2 diabetes mellitus - a population-based study |
10 |
| One-stage posterior approach for treating multilevel noncontiguous thoracic and lumbar spinal tuberculosis |
9 |
| Pulmonary complications of influenza infection: a targeted narrative review |
9 |
| Cardiovascular safety of non-steroidal anti-inflammatory drugs revisited |
7 |
| Normalizing fibromyalgia as a chronic illness |
7 |
| Pulmonary lymphangitis carcinomatosis: systematic review and meta-analysis of case reports, 1970-2018 |
7 |
| Real-world misuse, abuse, and dependence of abuse-deterrent versus non-abuse-deterrent extended-release morphine in Medicaid non-cancer patients |
7 |
| Gastrointestinal safety and tolerability of oral non-aspirin over-the-counter analgesics |
7 |
| Prevalence and risk factors of microalbuminuria in patients with lacunar infarction |
7 |
| Glycemia management in acute ischemic stroke: current concepts and novel therapeutic targets |
6 |
| The effects of adjunctive intranasal oxytocin in patients with schizophrenia |
6 |
| Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status |
6 |
| MEW gene variants in children with Henoch-Schonlein purpura and association with clinical manifestations: a singie-center Mediterranean experience |
5 |
| Glycemic control of type 2 diabetes mellitus across stages of renal impairment: information for primary care providers |
5 |
| Cardiac involvement in beta-thalassaemia: current treatment strategies |
5 |
| SGLT2 inhibitors: are they safe? |
5 |
| Incidence of rheumatoid arthritis, psoriatic arthritis and polymyalgia rheumatica in an inland area of central Italy: results of the CAMPO-RHE study |
5 |
| Topical therapies for knee osteoarthritis |
5 |
| Fecal markers in the management of inflammatory bowel disease |
5 |
| Serum interleukin-6 levels as an indicator of aseptic meningitis among children with enterovirus 71-induced hand, foot and mouth disease |
5 |
| Clinical manifestations of granulomatosis with polyangiitis: key considerations and major features |
4 |
| Canagliflozin and cardiovascular and renal events in type 2 diabetes |
4 |
| Validity of cardiometabolic index, lipid accumulation product, and body adiposity index in predicting the risk of hypertension in Chinese population |
4 |
| Risk of osteoporosis in microscopic colitis |
4 |
| Insulin non-persistence among people with type 2 diabetes: how to get your patients to stay on insulin therapy |
4 |
| Effects of SHP465 mixed amphetamine salts in adults with ADHD in a simulated adult workplace environment |
4 |
| Evaluating the clinical value of the hypoxia burden index in patients with obstructive sleep apnea |
4 |
| A randomized, double-blind study of SHP465 mixed amphetamine salts extended-release in adults with ADHD using a simulated adult workplace design |
3 |
| Bacterial vaginosis: a primer for clinicians |
3 |
| Early insights into the characteristics and evolution of clinical parameters in a cohort of patients prescribed sacubitril/valsartan in Germany |
3 |
| The non-medical switching of prescription medications |
3 |
| HLA-DRB1 differences in allelic distribution between familial and sporadic multiple sclerosis in a Hellenic cohort |
3 |
| Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience |
3 |
| The prognostic impact of TP53 comutation in EGFR mutant lung cancer patients: a systematic review and meta-analysis |
3 |
